Researchers Say Social Media Warning Is Too Broad
Posted inChildren and Childhood Depression (Mental) Haidt, Jonathan Labeling and Labels (Product) Mental Health and Disorders Murthy, Vivek H Odgers, Candice L Parenting Psychology and Psychologists Research Social Media Surgeon General (US) Teenagers and Adolescence United States your-feed-healthcare your-feed-science Youth

Researchers Say Social Media Warning Is Too Broad

Some scientists who study youth mental health say the evidence does not support the notion that social media is harmful per se.
FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flaws
Posted inAlternative and Complementary Medicine American Psychiatric Assn Clinical Trials Depression (Mental) Drug Abuse and Traffic Drug Enforcement Administration Drugs (Pharmaceuticals) Ecstasy (Drug) Food and Drug Administration MAPS Public Benefit Corp Mental Health and Disorders Placebos Post-Traumatic Stress Disorder Psychedelic and Hallucinogenic Drugs Regulation and Deregulation of Industry Research Therapy and Rehabilitation Veterans

FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flaws

The agency’s staff analysis suggests that approval of the illegal drug known as Ecstasy for treatment of PTSD is far from certain, with advisers meeting next week to consider the proposed therapy.
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapy
Posted inBrain Clinical Trials Depression (Mental) Drug Abuse and Traffic Drug Enforcement Administration Drugs (Pharmaceuticals) Food and Drug Administration Heart Mental Health and Disorders Opioids and Opiates Pain-Relieving Drugs Post-Traumatic Stress Disorder Psychedelic and Hallucinogenic Drugs Research Therapy and Rehabilitation

Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapy

New research is stirring interest in ibogaine, which appears to help ease the agony of detox and prevent relapse. Used in other countries, it remains illegal in the U.S.